Previous close | 0.2300 |
Open | 0.1800 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.2050 - 0.2399 |
52-week range | 0.2050 - 0.2399 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 3.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BRANFORD, Conn., April 30, 2024--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the Platinum® instrument.
BRANFORD, Conn., April 18, 2024--Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
BRANFORD, Conn., March 21, 2024--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors.